Background The complex interactions between recurrent trypsin-mediated pancreatic injury, alcohol-associated pancreatic injury and SPINK1 polymorphisms in chronic pancreatitis (CP) are undefined. We hypothesize that CP occurs as a result of multiple pathological mechanisms (pathways) that are initiated by different metabolic or environmental factors (etiologies) and may be influenced differentially by downstream genetic risk factors. We tested this hypothesis by evaluating the differences in effect size of the high risk SPINK1 N34S haplotype on CP from multiple etiologies after combining clinical reports of SPINK1 N34S frequency using meta-analysis. Methods and Findings The Pubmed and the Embase databases were reviewed. We studied 24 reports of SPINK1 N34S in CP (2,421 cases, 4,857 controls) using reported etiological factors as surrogates for pathways and multiple meta-analyses to determine the differential effects of SPINK1 N34S between alcoholic and non-alcoholic etiologies. Using estimates of between-study heterogeneity, we sub-classified our 24 studies into four specific clusters. We found that SPINK1 N34S is strongly associated with CP overall (OR 11.00; 95% CI: 7.59–15.93), but the effect of SPINK1 N34S in alcoholic CP (OR 4.98, 95% CI: 3.16–7.85) was significantly smaller than in idiopathic CP (OR 14.97, 95% C.I. = 9.09–24.67) or tropical CP (OR 19.15, 95% C.I. = 8.83–41.56). Studies analyzing familial CP showed very high heterogeneity suggestive of a complex etiology with an I2 = 80.95%. Conclusion The small effect of SPINK1 N34S in alcoholic subjects suggests that CP is driven through a different pathway that is largely trypsin-independent. The results also suggest that large effect sizes of SPINK1 N34S in small candidate gene studies in CP may be related to a mixture of multiple etiologic pathways leading to the same clinical endpoint.
References
[1]
Sarles H, Adler G, Dani R, Frey C, Gullo L, et al. (1989) The pancreatitis classification of Marseilles-Rome 1988. Scand J Gastroenterol 24: 641–642.
[2]
Whitcomb DC (2006) Clinical practice. Acute pancreatitis. N Engl J Med 354: 2142–2150.
[3]
Etemad B, Whitcomb DC (2001) Chronic pancreatitis: diagnosis, classification, and new genetic developments. Gastroenterology 120: 682–707.
[4]
Steer ML, Waxman I, Freedman S (1995) Chronic pancreatitis. N Engl J Med 332: 1482–1490.
[5]
Warshaw AL, Banks PA, Fernandez-Del Castillo C (1998) AGA technical review: treatment of pain in chronic pancreatitis. Gastroenterology 115: 765–776.
[6]
Bachem MG, Zhou Z, Zhou S, Siech M (2006) Role of stellate cells in pancreatic fibrogenesis associated with acute and chronic pancreatitis. J Gastroenterol Hepatol 21: Suppl 3S92–96.
[7]
Omary MB, Lugea A, Lowe AW, Pandol SJ (2007) The pancreatic stellate cell: a star on the rise in pancreatic diseases. J Clin Invest 117: 50–59.
[8]
Lankisch PG, Lowenfels AB, Maisonneuve P (2002) What is the risk of alcoholic pancreatitis in heavy drinkers? Pancreas 25: 411–412.
[9]
Yadav D, Papachristou GI, Whitcomb DC (2007) Alcohol-associated pancreatitis. Gastroenterol Clin North Am 36: 219–238, vii.
[10]
Whitcomb DC, Gorry MC, Preston RA, Furey W, Sossenheimer MJ, et al. (1996) Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat Genet 14: 141–145.
[11]
Cohn JA, Friedman KJ, Noone PG, Knowles MR, Silverman LM, et al. (1998) Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis. N Engl J Med 339: 653–658.
[12]
Sharer N, Schwarz M, Malone G, Howarth A, Painter J, et al. (1998) Mutations of the cystic fibrosis gene in patients with chronic pancreatitis. N Engl J Med 339: 645–652.
[13]
Chen JM, Mercier B, Audrezet MP, Ferec C (2000) Mutational analysis of the human pancreatic secretory trypsin inhibitor (PSTI) gene in hereditary and sporadic chronic pancreatitis. J Med Genet 37: 67–69.
[14]
Pfutzer RH, Barmada MM, Brunskill AP, Finch R, Hart PS, et al. (2000) SPINK1/PSTI polymorphisms act as disease modifiers in familial and idiopathic chronic pancreatitis. Gastroenterology 119: 615–623.
[15]
Witt H, Luck W, Hennies HC, Classen M, Kage A, et al. (2000) Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis. Nat Genet 25: 213–216.
[16]
Khalid A, Finkelstein S, Thompson B, Kelly L, Hanck C, et al. (2006) A 93 year old man with the PRSS1 R122H mutation, low SPINK1 expression, and no pancreatitis: insights into phenotypic non-penetrance. Gut 55: 728–731.
[17]
Lasson A, Borgstrom A, Ohlsson K (1986) Elevated pancreatic secretory trypsin inhibitor levels during severe inflammatory disease, renal insufficiency, and after various surgical procedures. Scand J Gastroenterol 21: 1275–1280.
[18]
Ogawa M (1988) Pancreatic secretory trypsin inhibitor as an acute phase reactant. Clin Biochem 21: 19–25.
[19]
Whitcomb DC (2002) How to think about SPINK and pancreatitis. Am J Gastroenterol 97: 1085–1088.
[20]
Ioannidis JP, Ntzani EE, Trikalinos TA, Contopoulos-Ioannidis DG (2001) Replication validity of genetic association studies. Nat Genet 29: 306–309.
[21]
Ioannidis JP, Trikalinos TA, Ntzani EE, Contopoulos-Ioannidis DG (2003) Genetic associations in large versus small studies: an empirical assessment. Lancet 361: 567–571.
[22]
Trikalinos TA, Ntzani EE, Contopoulos-Ioannidis DG, Ioannidis JP (2004) Establishment of genetic associations for complex diseases is independent of early study findings. Eur J Hum Genet 12: 762–769.
[23]
Lau J, Ioannidis JP, Schmid CH (1998) Summing up evidence: one answer is not always enough. Lancet 351: 123–127.
[24]
Ioannidis JP, Patsopoulos NA, Evangelou E (2007) Heterogeneity in meta-analyses of genome-wide association investigations. PLoS ONE 2: e841.
[25]
Whitcomb DC, Barmada MM (2007) A systems biology approach to genetic studies of pancreatitis and other complex diseases. Cell Mol Life Sci.
[26]
Ioannidis JP, Patsopoulos NA, Evangelou E (2007) Uncertainty in heterogeneity estimates in meta-analyses. Bmj 335: 914–916.
[27]
Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21: 1539–1558.
[28]
Keiles S, Kammesheidt A (2006) Identification of CFTR, PRSS1, and SPINK1 mutations in 381 patients with pancreatitis. Pancreas 33: 221–227.
[29]
Kume K, Masamune A, Mizutamari H, Kaneko K, Kikuta K, et al. (2005) Mutations in the serine protease inhibitor Kazal Type 1 (SPINK1) gene in Japanese patients with pancreatitis. Pancreatology 5: 354–360.
[30]
Rossi L, Pfutzer RH, Parvin S, Ali L, Sattar S, et al. (2001) SPINK1/PSTI mutations are associated with tropical pancreatitis in Bangladesh. A preliminary report. Pancreatology 1: 242–245.
[31]
Masamune A, Kume K, Shimosegawa T (2007) Differential roles of the SPINK1 gene mutations in alcoholic and nonalcoholic chronic pancreatitis. J Gastroenterol 42: Suppl 17135–140.
[32]
Bernardino AL, Guarita DR, Mott CB, Pedroso MR, Machado MC, et al. (2003) CFTR, PRSS1 and SPINK1 mutations in the development of pancreatitis in Brazilian patients. Jop 4: 169–177.
[33]
Whitcomb DC, Aoun E, Vodovotz Y, Clermont G, Barmada MM (2005) Evaluating disorders with a complex genetics basis. the future roles of meta-analysis and systems biology. Dig Dis Sci 50: 2195–2202.
[34]
Deng X, Wood PG, Eagon PK, Whitcomb DC (2004) Chronic alcohol-induced alterations in the pancreatic secretory control mechanisms. Dig Dis Sci 49: 805–819.
[35]
Katz M, Carangelo R, Miller LJ, Gorelick F (1996) Effect of ethanol on cholecystokinin-stimulated zymogen conversion in pancreatic acinar cells. Am J Physiol 270: G171–175.
[36]
Whitcomb DC (2004) Value of genetic testing in the management of pancreatitis. Gut 53: 1710–1717.
[37]
Apte MV, Phillips PA, Fahmy RG, Darby SJ, Rodgers SC, et al. (2000) Does alcohol directly stimulate pancreatic fibrogenesis? Studies with rat pancreatic stellate cells. Gastroenterology 118: 780–794.
[38]
Fortunato F, Deng X, Gates LK, McClain CJ, Bimmler D, et al. (2006) Pancreatic response to endotoxin after chronic alcohol exposure: switch from apoptosis to necrosis? Am J Physiol Gastrointest Liver Physiol 290: G232–241.
[39]
Wang YL, Hu R, Lugea A, Gukovsky I, Smoot D, et al. (2006) Ethanol feeding alters death signaling in the pancreas. Pancreas 32: 351–359.
[40]
Mahurkar S, Idris MM, Reddy DN, Bhaskar S, Rao GV, et al. (2006) Association of cathepsin B gene polymorphisms with tropical calcific pancreatitis. Gut 55: 1270–1275.
[41]
Halangk W, Lerch MM, Brandt-Nedelev B, Roth W, Ruthenbuerger M, et al. (2000) Role of cathepsin B in intracellular trypsinogen activation and the onset of acute pancreatitis. J Clin Invest 106: 773–781.
[42]
Szilagyi L, Kenesi E, Katona G, Kaslik G, Juhasz G, et al. (2001) Comparative in vitro studies on native and recombinant human cationic trypsins. Cathepsin B is a possible pathological activator of trypsinogen in pancreatitis. J Biol Chem 276: 24574–24580.
[43]
Noone PG, Zhou Z, Silverman LM, Jowell PS, Knowles MR, et al. (2001) Cystic fibrosis gene mutations and pancreatitis risk: relation to epithelial ion transport and trypsin inhibitor gene mutations. Gastroenterology 121: 1310–1319.
[44]
Schneider A, Whitcomb DC (2002) Hereditary pancreatitis: a model for inflammatory diseases of the pancreas. Best Pract Res Clin Gastroenterol 16: 347–363.
[45]
Whitcomb DC (2004) Mechanisms of disease: Advances in understanding the mechanisms leading to chronic pancreatitis. Nat Clin Pract Gastroenterol Hepatol 1: 46–52.
[46]
Plendl H, Siebert R, Steinemann D, Grote W (2001) High frequency of the N34S mutation in the SPINK1 gene in chronic pancreatitis detected by a new PCR-RFLP assay. Am J Med Genet 100: 252–253.
[47]
Witt H, Luck W, Becker M, Bohmig M, Kage A, et al. (2001) Mutation in the SPINK1 trypsin inhibitor gene, alcohol use, and chronic pancreatitis. Jama 285: 2716–2717.
[48]
Chen JM, Mercier B, Audrezet MP, Raguenes O, Quere I, et al. (2001) Mutations of the pancreatic secretory trypsin inhibitor (PSTI) gene in idiopathic chronic pancreatitis. Gastroenterology 120: 1061–1064.
[49]
Kaneko K, Nagasaki Y, Furukawa T, Mizutamari H, Sato A, et al. (2001) Analysis of the human pancreatic secretory trypsin inhibitor (PSTI) gene mutations in Japanese patients with chronic pancreatitis. J Hum Genet 46: 293–297.
[50]
Threadgold J, Greenhalf W, Ellis I, Howes N, Lerch MM, et al. (2002) The N34S mutation of SPINK1 (PSTI) is associated with a familial pattern of idiopathic chronic pancreatitis but does not cause the disease. Gut 50: 675–681.
[51]
Chandak GR, Idris MM, Reddy DN, Bhaskar S, Sriram PV, et al. (2002) Mutations in the pancreatic secretory trypsin inhibitor gene (PSTI/SPINK1) rather than the cationic trypsinogen gene (PRSS1) are significantly associated with tropical calcific pancreatitis. J Med Genet 39: 347–351.
[52]
Drenth JP, te Morsche R, Jansen JB (2002) Mutations in serine protease inhibitor Kazal type 1 are strongly associated with chronic pancreatitis. Gut 50: 687–692.
[53]
Bhatia E, Choudhuri G, Sikora SS, Landt O, Kage A, et al. (2002) Tropical calcific pancreatitis: strong association with SPINK1 trypsin inhibitor mutations. Gastroenterology 123: 1020–1025.
[54]
Hassan Z, Mohan V, Ali L, Allotey R, Barakat K, et al. (2002) SPINK1 is a susceptibility gene for fibrocalculous pancreatic diabetes in subjects from the Indian subcontinent. Am J Hum Genet 71: 964–968.
[55]
Schneider A, Suman A, Rossi L, Barmada MM, Beglinger C, et al. (2002) SPINK1/PSTI mutations are associated with tropical pancreatitis and type II diabetes mellitus in Bangladesh. Gastroenterology 123: 1026–1030.
[56]
Audrezet MP, Chen JM, Le Marechal C, Ruszniewski P, Robaszkiewicz M, et al. (2002) Determination of the relative contribution of three genes-the cystic fibrosis transmembrane conductance regulator gene, the cationic trypsinogen gene, and the pancreatic secretory trypsin inhibitor gene-to the etiology of idiopathic chronic pancreatitis. Eur J Hum Genet 10: 100–106.
[57]
Truninger K, Witt H, Kock J, Kage A, Seifert B, et al. (2002) Mutations of the serine protease inhibitor, Kazal type 1 gene, in patients with idiopathic chronic pancreatitis. Am J Gastroenterol 97: 1133–1137.
[58]
Schneider A, Pfutzer RH, Barmada MM, Slivka A, Martin J, et al. (2003) Limited contribution of the SPINK1 N34S mutation to the risk and severity of alcoholic chronic pancreatitis: a report from the United States. Dig Dis Sci 48: 1110–1115.
[59]
Gomez-Lira M, Bonamini D, Castellani C, Unis L, Cavallini G, et al. (2003) Mutations in the SPINK1 gene in idiopathic pancreatitis Italian patients. Eur J Hum Genet 11: 543–546.
[60]
Perri F, Piepoli A, Stanziale P, Merla A, Zelante L, et al. (2003) Mutation analysis of the cystic fibrosis transmembrane conductance regulator (CFTR) gene, the cationic trypsinogen (PRSS1) gene, and the serine protease inhibitor, Kazal type 1 (SPINK1) gene in patients with alcoholic chronic pancreatitis. Eur J Hum Genet 11: 687–692.
[61]
Matsubayashi H, Fukushima N, Sato N, Brune K, Canto M, et al. (2003) Polymorphisms of SPINK1 N34S and CFTR in patients with sporadic and familial pancreatic cancer. Cancer Biol Ther 2: 652–655.
[62]
Chandak GR, Idris MM, Reddy DN, Mani KR, Bhaskar S, et al. (2004) Absence of PRSS1 mutations and association of SPINK1 trypsin inhibitor mutations in hereditary and non-hereditary chronic pancreatitis. Gut 53: 723–728.
[63]
Lempinen M, Paju A, Kemppainen E, Smura T, Kylanpaa ML, et al. (2005) Mutations N34S and P55S of the SPINK1 gene in patients with chronic pancreatitis or pancreatic cancer and in healthy subjects: a report from Finland. Scand J Gastroenterol 40: 225–230.
[64]
Lee KH, Ryu JK, Yoon WJ, Lee JK, Kim YT, et al. (2005) Mutation analysis of SPINK1 and CFTR gene in Korean patients with alcoholic chronic pancreatitis. Dig Dis Sci 50: 1852–1856.
[65]
Shimosegawa T, Kume K, Masamune A (2006) SPINK1 gene mutations and pancreatitis in Japan. J Gastroenterol Hepatol 21: Suppl 3S47–51.
[66]
Sobczynska-Tomaszewska A, Bak D, Oralewska B, Oracz G, Norek A, et al. (2006) Analysis of CFTR, SPINK1, PRSS1 and AAT mutations in children with acute or chronic pancreatitis. J Pediatr Gastroenterol Nutr 43: 299–306.
[67]
Tzetis M, Kaliakatsos M, Fotoulaki M, Papatheodorou A, Doudounakis S, et al. (2007) Contribution of the CFTR gene, the pancreatic secretory trypsin inhibitor gene (SPINK1) and the cationic trypsinogen gene (PRSS1) to the etiology of recurrent pancreatitis. Clin Genet 71: 451–457.
